Niagen Bioscience GAAP EPS of $0.05 beats by $0.03, revenue of $33.84M beats by $2.14M
Source: SeekingAlpha
2026-03-04 16:10:52 ET
More on Niagen Bioscience
- Niagen Bioscience: Why Discipline Matters In A Crowded Supplement Market
- Niagen Bioscience acquires core Nicotinamide Riboside patents
- Seeking Alpha’s Quant Rating on Niagen Bioscience
- Historical earnings data for Niagen Bioscience
- Financial information for Niagen Bioscience
Read the full article on Seeking Alpha
For further details see:
Niagen Bioscience GAAP EPS of $0.05 beats by $0.03, revenue of $33.84M beats by $2.14M
Niagen Bioscience Inc.
NASDAQ: NAGE
NAGE Trading
-5.98% G/L:
$4.955 Last:
743,403 Volume:
$5.17 Open:
NAGE Latest News
March 10, 2026 08:32:00 am
Niagen Bioscience Launches Niagen® Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen NanoCloud(TM), From Tru Niagen Powered by Patented Niagen®
NAGE Stock Data
$408,607,432
52,743,877
N/A
66
N/A
Biotechnology & Life Sciences
Healthcare
US
Los Angeles
